In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.
Henry
Amanda
A
Kennedy
Debra
D
Lowe
Sandra
S
D000322:Adrenergic Agonists / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000139:chemically induced*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*
D000322:Adrenergic Agonists